Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S1204 Viral Screening Study 8/29/2013 2/15/2017 100%
    Closed S1312 PI/II Inotuzumab + CVP for R/R CD22+ ALL 4/1/2014 8/2/2019 100%
    Closed S1304 RPII Dex + High or Low Dose Carfilzomib for R/R MM 10/18/2013 5/15/2016 100%
    Closed S1320 Melanoma - Ph II Intermittent vs Continuous Dabrafenib and Trametinib BRAF Positive Melanoma 7/22/2014 7/15/2019 100%
    Closed S1314 Phase II COXEN Trial for Localized Bladder Cancer 7/9/2014 12/1/2017 100%
    Closed S1406 Rano Ph II of Irino+Cetuximab +/- Vemurafenib in BRAF mutant mCRC 11/13/2014 4/1/2016 100%
    Closed S1316 Surgery vs Non-Surgical Management for MBO 3/9/2015 100%
    Closed S1500 PhII: MET inhibitors for papillary RCC 4/5/2016 100%
    Closed S1417CD Impact of Cancer on Finances 4/15/2016 2/1/2019 100%
    Closed S1416 Ph II Cisplatin +/- ABT 888 in Metastatic TNBC and/or BRCA 7/7/2016 6/15/2019 100%
    Closed S1507 Ph II Tram + doce with kras NSCLC + and PD 7/18/2016 3/15/2018 100%
    Closed S1512 Desmoplastic study 10/20/2016 100%
    Closed S1602 BCG Strain Differences and BCG vaccination in High-Grade Non-Muscle Invasive Bladder Cancer 2/7/2017 12/15/2020 100%
    Closed S1616 Ipilimumab + Nivolmab in Adv Melanoma follow prog on PD-1 Inhibitor 7/17/2017 100%
    Closed S1619 Neoadjuvant Cisplatin-Pemetrexed with Atezolizumab 11/3/2017 5/1/2020 100%
    Closed S1702 Ph II AL amyloidosis isatuximab 3/8/2018 9/30/2019 100%
    Open S1803 PIII Daratumumab + Lenalidomide Post-Auto SCT Maint for MM 6/27/2019 100%
    Closed S1815 Phase III Randomized for advanced biliary tract cancers 12/3/2018 2/15/2021 100%
    Closed S1801 Ph II Ramdomization for Clinically Detectable Stage III-IV High-risk Melanoma 12/6/2018 5/5/2022 100%
    Closed S1600 Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes 2/21/2019 10/20/2023 100%
    Scroll Table